What You Need to Know About Bipolar Depression
You must understand that bipolar disorder is a kind of condition which affects all types of individuals. The children and adults are being affected by such condition. Such is a fact that you must understand. Women would suffer the most from this kind of depression that is called bipolar depression disorder.
This is not really strange or far-fetched in any case because even if the women would suffer from the regular bipolar type of depression or depressive disorder, they are going to spend more time depressed than they would do being manic. Not just women are depressive but the men would also get affected by such kind of condition.
The bipolar type of disorder is known as manic depression because this is a mental condition wherein you would interchange often between the phases of mania and depression. If you suffer from such bipolar depression, you won’t have to spend a lot of time being manic as you spend getting depressed.
This kind of depression is one form of disorder and you should understand it is easy to wrongly diagnose as bipolar disorder due to the similarity of such symptoms. Because of such, the doctor must keep you around for such a long time when they would try to diagnose the condition you have. It is definitely not flattering to either of you if you would be treated for a wrong thing.
Such bipolar affective disorder is another name for the bipolar disorder or such manic-depressive illness. However, you don’t want to mistake such for bipolar depression disorder. Such is related with those symptoms of such depressive phase of bipolar disorder but only a few of the mania.
The monotherapy trials against the placebo continue to be the gold-standard design when it comes to determining the efficacy in bipolar depression. If the efficacy would get proven as monotherapy, those new compounds can be tested in the adjunctive-medication placebo-controlled trials. Those younger adults, without such established need for the long-term medication can be suitable for those clinical trials that require placebo-controls. The switch to mania or hypomania can be the consequence of such active treatment for the bipolar depression.
Some medications like the tricyclic antidepressants and the venlafaxine can be more likely to prove switch as compared to the others but the increased rate of the switch can’t be seen until about 10 weeks of treatment. Hence, the 12-week trials against placebo are required to determine such risk of switch and to establish such continuing effects. You have to know that such careful assessment at six to eight weeks are needed to guarantee that the patients who fail to respond won’t continue in the study for such unacceptable periods of time.